AstraZeneca is adding a new heart warning to the labels of Seroquel, its blockbuster antipsychotic drug, at the request of the Food and Drug Administration, company and agency officials said on Monday.

Warnings for Seroquel will soon recommend that the drug be avoided in combination with 12 drugs linked to arrhythmia.

The revised label, posted without fanfare last week on the F.D.A.